Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-10-17Clinical Trial Update: Milademetan in Advanced/Metastatic Solid Tumors [Phase 2]
A Phase 2 trial of milademetan in advanced or metastatic solid tumors was terminated, with results posted in October 2024.
-
CLINICAL_TRIALS research · 2024-10-17Clinical Trial Update: Phase IIT Trial of SNA014 [EARLY_Phase 1]
Early-phase trial update for SNA014 by SmartNuclide Biopharma targeting gastric and gastroesophageal junction adenocarcinomas; the study is …
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: BGT007 Treatment for Recurrent/refractory Gastrointestinal Malignancies [EARLY_Phase 1]
Notes an early Phase 1 trial of BGT007 for recurrent or refractory gastrointestinal cancers, including colorectal and pancreatic cancers, wh…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Differentiation Benign and Malignant Pancreatic Lesions
The clinical trial update reports the completed study evaluating methods to differentiate benign versus malignant pancreatic lesions.
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer [Phase 2]
A Phase 2 trial evaluating pembrolizumab to modulate the gut microbiome after chemotherapy in resectable pancreatic cancer. The study is cur…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics [NA]
Clinical trial registry entry describing an ongoing targeted-agent evaluation in digestive cancers in China based on molecular characteristi…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Pancreatic Cancer Early Detection Registry
The Pancreatic Cancer Early Detection Registry trial (NCT05519930) has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Palliative Stereotactic Radiation for Pancreatic or Periampullary Adenocarcinoma [Phase 2]
A Phase 2 trial evaluating palliative stereotactic radiation therapy for pancreatic cancer and periampullary adenocarcinoma has completed en…
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: APN401 in Treating Patients With Recurrent or Metastatic Pancreatic Cancer, Colorectal Cancer, or Other Solid Tumors That Cannot Be Removed by Surgery [Phase 1]
APN401 was evaluated in a Phase 1 trial for patients with recurrent or metastatic pancreatic cancer, colorectal cancer, and unresectable sol…
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors [Phase 1]
A Phase 1 study of NGM831 as a monotherapy and in combination with pembrolizumab (with or without NGM438) in advanced or metastatic solid tu…
-
CLINICAL_TRIALS research · 2024-10-09Clinical Trial Update: AI-Assisted Non-Contrast CT for Multi-Cancer Screening [NA]
An ongoing study evaluating AI-assisted non-contrast CT for multi-cancer screening is currently recruiting, covering several cancers includi…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Immunologic Effects of CDX-301 and CDX-1140 in Resectable Pancreatic Cancer Patients [Phase 2]
A Phase 2 trial evaluating immunologic effects of CDX-301 and CDX-1140 in resectable pancreatic cancer has been terminated, and results have…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Long-term Survival Outcomes According to the Pathologic Response After Neoadjuvant Treatment in PDAC and the Fate of the Patients with Good CAP Grade
This clinical trial update reports long-term survival outcomes in pancreatic cancer patients treated with neoadjuvant therapy, evaluating re…
-
CLINICAL_TRIALS other · 2024-10-04Clinical Trial Update: Para-aortic Lymphnodes Removal During Upfront Pancreaticoduodenectomy [NA]
ClinicalTrials.gov trial NCT04571294 evaluates para-aortic lymph node removal during upfront pancreaticoduodenectomy for pancreatic cancer, …
-
CLINICAL_TRIALS research · 2024-10-03Clinical Trial Update: Pharmacotyping of Pancreatic Patient-derived Organoids
This clinical trial update describes pharmacotyping of pancreatic cancer patient-derived organoids to guide personalized therapy. The study …
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors [Phase 1, Phase 2]
Phase 1/2 trial of BNT141 in CLDN18.2-positive gastric, pancreatic, ovarian, and biliary tract cancers. The study was terminated and results…
-
CLINICAL_TRIALS research · 2024-10-02Clinical Trial Update: Study of PRO in Patients with Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay) [NA]
Clinical trial update describing a study focusing on patient-reported outcomes in advanced pancreatic cancer or non-small cell lung cancer t…
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: Olaparib in Treating Patients With Stage IV Pancreatic Cancer [Phase 2]
This Phase 2 trial evaluated olaparib in patients with Stage IV pancreatic cancer, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: TP53 R248Q TCR-T Cell Therapy for Advanced Solid Tumor [EARLY_Phase 1]
Early-phase trial of TP53 R248Q-targeted TCR-T cell therapy for advanced solid tumors is not yet recruiting. The trial lists lung adenocarci…
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
Clinical trial update on detecting tumor cells and tumor DNA in blood, urine, and bone marrow of patients with solid cancers; the study is c…
-
CLINICAL_TRIALS trial_result · 2024-09-27Clinical Trial Update: A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors [Phase 1]
Phase 1 study of LY3300054, an anti-PD-L1 antibody, given alone or in combination in adults with advanced refractory solid tumors, including…
-
CLINICAL_TRIALS trial_result · 2024-09-27Clinical Trial Update: A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway [Phase 1]
This clinical trial update describes a Phase 1 study of the PARP inhibitor DAT-2645 monotherapy for advanced/metastatic solid tumors harbori…
-
CLINICAL_TRIALS trial_result · 2024-09-26Clinical Trial Update: Quality of Life of Patients Over 75 Yars Undergoing Palliative Chemotherapy
The update notes a terminated clinical trial evaluating quality of life in patients over 75 undergoing palliative chemotherapy for several g…
-
CLINICAL_TRIALS trial_result · 2024-09-25Clinical Trial Update: A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 bioequivalence study comparing the proposed talazoparib capsule formulation to the current formulation, plus a food-effect assessmen…
-
CLINICAL_TRIALS research · 2024-09-25Clinical Trial Update: Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer [Phase 1, Phase 2]
A clinical trial update describing the investigation of Antroquinonol in combination with standard of care for first-line metastatic pancrea…